Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa.
Osteoporos Sarcopenia
; 9(4): 137-141, 2023 Dec.
Article
em En
| MEDLINE
| ID: mdl-38374824
ABSTRACT
Objectives:
This study aims to investigate the effects of romosozumab on bone mineral density (BMD) and bone metabolism.Methods:
In this retrospective case series, romosozumab was administered to 5 premenopausal female patients with osteoporosis and anorexia nervosa with fragility fractures. BMD and bone turnover marker changes were investigated at 6 months and 1 year after administering romosozumab.Results:
BMD increased and high-turnover bone metabolism decreased 6 months and 1 year after administering romosozumab.Conclusions:
Romosozumab is useful for treating osteoporosis in patients with anorexia nervosa.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Osteoporos Sarcopenia
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Japão